Astera Labs (NASDAQ:ALAB) Trading Up 9% – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price rose 9% during trading on Wednesday . The company traded as high as $126.81 and last traded at $126.9420. Approximately 1,812,747 shares traded hands during trading, a decline of 66% from the average daily volume of 5,362,035 shares. The stock had previously closed at $116.48.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of recent analyst reports. Wall Street Zen cut Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Loop Capital assumed coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Raymond James Financial assumed coverage on Astera Labs in a research note on Friday, November 21st. They set a “hold” rating for the company. BNP Paribas Exane began coverage on Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating on the stock. Finally, Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $195.89.

Astera Labs Stock Performance

The stock has a market cap of $21.35 billion, a price-to-earnings ratio of 103.03, a PEG ratio of 2.41 and a beta of 1.74. The firm’s 50-day moving average price is $150.84 and its two-hundred day moving average price is $169.21.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same period in the previous year, the firm earned $0.37 earnings per share. Astera Labs’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $117.47, for a total value of $1,174,700.00. Following the sale, the general counsel owned 128,084 shares in the company, valued at $15,046,027.48. The trade was a 7.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief executive officer directly owned 1,452,739 shares in the company, valued at approximately $179,863,615.59. This trade represents a 6.14% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 224,292 shares of company stock worth $27,676,069. 12.50% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

A number of hedge funds and other institutional investors have recently modified their holdings of ALAB. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Astera Labs by 94.6% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after acquiring an additional 53,276 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Astera Labs by 34.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock valued at $47,208,000 after acquiring an additional 133,961 shares during the period. Geneva Partners LLC acquired a new position in shares of Astera Labs in the 3rd quarter worth approximately $1,876,000. Corient Private Wealth LLC purchased a new position in shares of Astera Labs during the 2nd quarter worth approximately $543,000. Finally, Handelsbanken Fonder AB increased its holdings in Astera Labs by 289.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after purchasing an additional 93,800 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.